GlaxoSmithKline: all 4,196 studies
Page 40 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With HypereosinophilicNo longer availableNCT00244686
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced AdultsTerminatedNCT00242879Phase 2
- Use Of GW274150 In The Prophylactic Treatment Of MigraineCompletedNCT00242866Phase 2
- A Study To Investigate Markers Of Inflammation In Rheumatoid ArthritisCompletedNCT00242853
- Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)CompletedNCT00242840Phase 3
- AVANDAMET Versus Metformin For Type 2 Diabetes MellitusCompletedNCT00241605Phase 4
- Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For StrokeCompletedNCT00240643Phase 2
- Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksCompletedNCT00240630Phase 3
- Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksCompletedNCT00240617Phase 3
- Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 TositumomabCompletedNCT00240591
- Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 TositumomabCompletedNCT00240578
- Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00240565Phase 2
- Fosamprenavir Expanded AccessCompletedNCT00240552Phase 4
- Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean PopulationCompletedNCT00237991
- Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and OverCompletedNCT00232947Phase 3
- Rosiglitazone And Plaque Study for Type 2 Diabetes MellitusCompletedNCT00231387Phase 3
- Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 YrsCompletedNCT00227422Phase 4
- A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)CompletedNCT00225862Phase 3
- Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
- Long Term Safety Of GW685698X Via Nasal BiopsyCompletedNCT00224523Phase 3
- A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using LithiumCompletedNCT00224510Phase 3
- A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's DiseaseCompletedNCT00224497Phase 2
- Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex VaccineCompletedNCT00224471Phase 3
- European Study of 3APS in Mild to Moderate Alzheimer's Disease PatientsStatus unknownNCT00217763Phase 3
- Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.Status unknownNCT00216242Phase 3
- Study Comparing the Immune Response of Fluarix and Fluzone Influenza VaccinesCompletedNCT00197288Phase 3
- Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsCompletedNCT00197275Phase 3
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
- Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & ImmunogenicityCompletedNCT00197249Phase 3
- Post-marketing Study to Evaluate the Efficacy of Influenza VaccineCompletedNCT00197223Phase 3
- A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy InfantsCompletedNCT00197210Phase 3
- Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNCT00197197Phase 3
- Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B VaccineCompletedNCT00197171Phase 3
- Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune ResponseCompletedNCT00197158Phase 4
- Study In Patients With Insulin ResistanceCompletedNCT00197132Phase 3
- In-Patient Study In Schizophrenic PatientsCompletedNCT00197093Phase 1
- Ropinirole XR (Extended Release) In Patients With Restless Legs SyndromeCompletedNCT00197080Phase 3
- A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.CompletedNCT00197067Phase 1
- A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.CompletedNCT00197041Phase 2
- Study In People With Type 2 DiabetesCompletedNCT00196989Phase 2
- Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 YrsCompletedNCT00196963Phase 2
- Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 YearsCompletedNCT00196950Phase 2
- Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.CompletedNCT00196924Phase 3
- Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)CompletedNCT00169585Phase 3
- Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based ChemotherapyCompletedNCT00169572Phase 2
- Dyslipidemia Study Investigating The Increase In "Good Cholesterol"CompletedNCT00169559Phase 2
- Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.CompletedNCT00169546Phase 4
- Rollover Study Of Lapatinib In Cancer PatientsCompletedNCT00169533Phase 1
- SB-715992 In Combination With Docetaxel In Patients With Solid TumorsCompletedNCT00169520Phase 1
- Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)CompletedNCT00169507Phase 3
- Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18CompletedNCT00169494Phase 3
- A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate VaccineCompletedNCT00169481Phase 2
- Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy InfantsCompletedNCT00169455Phase 3
- Evaluation Of Valaciclovir In Patients With ChickenpoxCompletedNCT00169416Phase 3
- Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne VulgarisCompletedNCT00160394Phase 4
- GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein CholesterolCompletedNCT00158899Phase 2
- Oral Topotecan As A Radiosensitizing Agent In Rectal CancerTerminatedNCT00158886Phase 1
- Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)SubjectsCompletedNCT00158873Phase 4
- Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma MedicationsCompletedNCT00158834Phase 3
- Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 MthsCompletedNCT00158808Phase 2
- Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw VaccineCompletedNCT00158795Phase 4
- Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer PatientsCompletedNCT00158782Phase 1
- A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged LiversCompletedNCT00158769Phase 1
- Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSACompletedNCT00148928Phase 1
- Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)CompletedNCT00148902Phase 1
- Post-marketing Safety Study of GSK Biological's Pediarix™ VaccineCompletedNCT00146835
- Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive AdultsCompletedNCT00146744Phase 2
- ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.CompletedNCT00144911Phase 4
- LAMICTAL (Lamotrigine) For The Treatment Of Absence SeizuresCompletedNCT00144872Phase 1
- Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144859Phase 2
- Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In ChildrenCompletedNCT00144846Phase 3
- Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsTerminatedNCT00144833Phase 3
- Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast CancerCompletedNCT00140738Phase 1
- Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
- Ropinirole Tablets In Young Patients With Restless Legs SyndromeCompletedNCT00140712Phase 1
- To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood VaccinesCompletedNCT00140686Phase 3
- A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.CompletedNCT00140673Phase 3
- Michelangelo - Oasis 5CompletedNCT00139815Phase 3
- Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy InfantsCompletedNCT00139347Phase 3
- A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in BangladeshCompletedNCT00139334Phase 2
- Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus GastroenteritisCompletedNCT00137930Phase 2
- Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 YrsCompletedNCT00137917Phase 2
- Ispinesib In Combination With Carboplatin In Patients With Solid TumorsCompletedNCT00136578Phase 1
- SB-743921 In Patients With Solid TumorsCompletedNCT00136513Phase 1
- Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy ToddlersCompletedNCT00135564Phase 2
- Study Of Generalized Anxiety DisorderCompletedNCT00135525Phase 2
- Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in InfantsCompletedNCT00135486Phase 2
- Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus GastroenteritisCompletedNCT00134732Phase 3
- A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid ArthritisCompletedNCT00134693Phase 2
- Topical SB-275833 Ointment, 1% For The Treatment Of ImpetigoCompletedNCT00133874Phase 3
- Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo OintmentCompletedNCT00133848Phase 3
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
- Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
- Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate VaccineCompletedNCT00126984Phase 2
- Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 YrsCompletedNCT00126945Phase 2
- COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And MicroalbuminuriaTerminatedNCT00123903Phase 3
- Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140TerminatedNCT00123890Phase 3
- Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The KneeCompletedNCT00120900Phase 3
- Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young AdultsCompletedNCT00120848Phase 2